Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-20

Clinical Trial Update: Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating fecal microbiota transplantation delivered via colonic transendoscopic enteral tubing for ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Ulcerative Colitis | Phase 4 | Status: UNKNOWN